Key takeaways
Specifically, to address the challenges encountered in implementing the aforementioned Regulations, which, in addition to preventing the certification and approval of medical devices and in vitro diagnostic medical devices, have resulted in shortages of same devices, thus restricting patient access to innovative and life-saving therapeutic and diagnostic technologies, the Resolution highlights the urgent need for action to streamline regulatory processes, improve transparency, and eliminate unnecessary administrative work for notified bodies and manufacturers.
The Resolution also calls on the European Commission to introduce fast-track and priority procedures for the approval of innovative technologies in areas where medical needs are not being met and for devices related to health emergencies, and stresses the need to establish a clear definition of an "orphan device" that can facilitate the adoption of harmonized measures throughout the EU.
Finally, in order to ensure continuous monitoring of device availability in the EU market, the Resolution stresses the need for full and urgent implementation of European database on medical devices (EUDAMED), so as to increase transparency and provide better access to relevant information.